News Releases

Apr 24, 2024
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
LOUISVILLE, Colo. --(BUSINESS WIRE)--Apr. 24, 2024-- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8 .
Feb 26, 2024
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
LOUISVILLE, Colo. --(BUSINESS WIRE)--Feb. 26, 2024-- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton , Chief Executive Officer of Biodesix , will present and host in-person 1x1 investor meetings at the TD Cowen